CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on th... CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia. Show more
Multikine is the first cancer immunotherapy to show pre-surgical tumor regression in head and neck cancer in just 3 weeks - confirmed by pathology at surgery Factors supporting the go-ahead for...
Biomarker used to select patients who are more likely have favorable outcomes, supporting a successful confirmatory Registration Study Patients with low PD-L1 expression treated with Multikine...
Oncologic Drugs Advisory Committee (ODAC) determines risks outweigh benefits in some cancers for frontline immune checkpoint inhibitors, including blockbuster drugs such as Keytruda and Opdivo...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0358 | 4.84438430311 | 0.739 | 1.09 | 0.6 | 2350945 | 0.72274648 | CS |
4 | 0.1703 | 28.1720430108 | 0.6045 | 1.09 | 0.4947 | 984281 | 0.68970761 | CS |
12 | -0.2852 | -26.9056603774 | 1.06 | 1.13 | 0.4947 | 562621 | 0.73398309 | CS |
26 | -0.3852 | -33.2068965517 | 1.16 | 2.2199 | 0.4947 | 917804 | 1.11908018 | CS |
52 | -1.9952 | -72.0288808664 | 2.77 | 3.23 | 0.4947 | 629368 | 1.34252248 | CS |
156 | -7.2052 | -90.290726817 | 7.98 | 8.565 | 0.4947 | 636506 | 2.65053603 | CS |
260 | -8.1752 | -91.3430167598 | 8.95 | 40.91 | 0.4947 | 768976 | 8.40889008 | CS |
Symbole | Prix | Vol. |
---|---|---|
SPYSPDR S&P 500 | US$ 591,15 (0,86%) | 122,49M |
SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 6,1628 (-3,25%) | 114,87M |
SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 27,30 (3,80%) | 108,08M |
TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 2,435 (7,27%) | 94,23M |
KULRKULR Technology Group Inc | US$ 2,885 (28,79%) | 75,72M |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales